Author

M. Frederiksen

h-index 16 View on Semantic Scholar

We have 2 of 44 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Interferon-α vs hydroxyurea in patients with myeloproliferative neoplasms (DALIAH): a multicentre, randomised, open-label, phase 3 trial in Denmark

Summary Background Hydroxyurea (HU) is the most commonly used cytoreductive treatment for patients with myeloproliferative neoplasms (MPN), but emerging data on pegylated interferon-alpha2 (pegIFNα) are encouraging. Optimal first-line treatment remains unclear. Methods DALIAH was a randomised, open-label, parallel-grou...

T. Knudsen, D. Hansen, L. F. Ocias et al. · EClinicalMedicine · 0 citations

Review Open access Oct 2026

Frailty and quality of life in a real-world multiple myeloma population.

The results based on a real-world population show that QoL findings from clinical trial populations cannot directly be applied to frail patients.

K. Rydahl, Sören Möller, T. Horsbøl et al. · British Journal of Haematolo... · 0 citations